The annual Pharmig conference in Nottingham, UK, revealed how greater understanding of microbial risks has increased the role of microbial testing labs, but also highlighted why there is a need for practice improvements. Susan Birks reports.
Microbiology services are crucial for trouble-free operation in pharmaceutical plants as microbiological issues can be hugely significant, resulting in plant shutdowns and products withdrawn from the market. Recent recipients of the FDA’s 483 forms show that no company is too big to fail. With this in mind, the two-day Pharmig conference held in Nottingham in November offered several best practice presentations on microbiology. From a full and informative programme three presentations have been chosen to highlight some common failings and some of the new methods for achieving improvements for the sector.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.